ORIGINAL ARTICLE Cell Research (2008): 1-17 BCL-XL regulates TNF-α-mediated cell death independently of NF-κB, FLIP and IAPsRaffaella Gozzelino1, Carme Sole1, Nuria Llecha2, Migue1 F Segura1, Rana S Moubarak3, Victoria Iglesias-Guimarais3, M Jose Perez-Garcia1, Stephanie Reix3,4, Jisheng Zhang1, Nahuai Badiola3,4, Daniel Sanchis1, Jose Rodriguez-Alvarez3,4, Ramon Trullas5, Victor J Yuste3,* and Joan X Comella1,3,4,* 1Cell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Montserrat Roig, 2, 25008 Lleida, Spain;2Departament de Patologia i Genètica Molecular, Hospital Universitari Arnau de Vilanova, Universitat de Lleida, Montserrat Roig, 2, 25008 Lleida, Spain 3Institut de Neurociències, Departament de Bioquímica i Biologia Molecular, Facultat de Medicina, Universitat Autònoma de Barcelona, Campus de Bellaterra (Edifici M), 08193 Bellaterra, Spain 4Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain; 5Neurobiology Unit, Institut d'Investigacions Biomèdiques de Barcelona, CSIC, IDIBAPS, 08036 Barcelona, Spain
QUpon activation, tumor necrosis factor alpha (TNF-α) receptor can engage apoptotic or survival pathways. Inhibition of macromolecular synthesis is known to sensitize cells to TNF-α-induced cell death. It is believed that this sensitization is due to the transcriptional blockade of genes regulated by NF-κB. Nevertheless, such evidence has remained elusive in the nervous system. Here, we show that TNF-α cannot normally induce apoptosis in PC12 cells or cortical neurons. However, cells treated with Actinomycin D (ActD) become susceptible to TNF-α-induced cell death through the activation of caspase-8, generation of tBid and activation of caspase-9 and -3. Analysis of several proteins involved in TNF-α receptor signaling showed no significant downregulation of NF-κB target genes, such as IAPs or FLIP, under such conditions. However, Bcl-xL protein levels, but not those of Bcl-2, Bax and Bak, are reduced by ActD or TNF-α/ActD treatments. Moreover, Bcl-xL overexpression fully protects cells against TNF-α/ActD-induced cell death. When endogenous levels of Bcl-xL are specifically downregulated by lentiviral-based RNAi, cells no longer require ActD to be sensitive to TNF-α-triggered apoptosis. Furthermore, Bcl-xL downregulation does not affect TNF-α-mediated NF-κB activation. Altogether, our results demonstrate that Bcl-xL, and not Bcl-2, FLIP or IAPs, acts as the endogenous regulator of neuronal resistance/sensitivity to TNF-α-induced apoptosis in an NF-κB-independent manner. Cell Research advance online publication 1 July 2008; doi: 10.1038/cr.2008.76 Keywords: apoptosis, Bcl-xL, neuron, NF-κB, PC12, TNF-α |
copyright©2006 Institute of Biochemistry and Cell Biology,SIBS,CAS
ISSN:1001-0602(Print),1748-7838(Online);CN:31-1568
suggested resolution 1024*768